Clinical trial
Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T…
NCT00192400 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00192400 |
|---|---|
| Title | Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children. |
| Official title | A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of One Dose and Two Doses of a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) Compared With Placebo in Healthy… |
| Lead sponsor | MedImmune LLC, Industry |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Biological |
| Interventions | CAIV-T |
| Enrollment | 2,160 |
| Start date | Mar 1, 2002 |
| Completion | Nov 1, 2002 |
| First posted | Sep 19, 2005 |
| Last update posted | Oct 3, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: